Showing results (1251-1260 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|September 7, 2024
The evidence base for the optimal antibiotic treatment duration of upper and lower respiratory tract infections: an umbrella reviewSuzanne M E Kuijpers, David T P Buis, Kirsten A Ziesemer, et al.
The Lancet. Infectious Diseases|August 8, 2024
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in BrazilMauricio L Nogueira, Monica A T Cintra, José A Moreira, et al.
The Lancet. Infectious Diseases|July 19, 2024
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trialSanthosh Kumar Ghadge, Martina Schneider, Katrin Dubischar, et al.
The Lancet. Infectious Diseases|July 22, 2024
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trialGlenda E Gray, Kathryn Mngadi, Ludo Lavreys, et al.
The Lancet. Infectious Diseases|July 28, 2024
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trialIsabel Leroux-Roels, Chittappen Kandiyil Prajeeth, Amare Aregay, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
The Lancet. Infectious Diseases|July 14, 2024
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trialJoseph Eiden, Carlos Fierro, Alexander White, et al.
The Lancet. Infectious Diseases|August 16, 2024
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007-22)Thi Mui Pham, Yue Zhang, McKenna Nevers, et al.
The Lancet. Infectious Diseases|August 16, 2024
Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trialKatrina Browne, Nicole M White, Philip L Russo, et al.
The Lancet. Infectious Diseases|May 9, 2024
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trialMichal Juraska, Angela M Early, Li Li, et al.
Pageof 271